Lifevantage Price to Sales Ratio 2010-2024 | LFVN
Historical PS ratio values for Lifevantage (LFVN) over the last 10 years. The current P/S ratio for Lifevantage as of December 20, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Lifevantage P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2024-12-20 |
17.36 |
|
1.14 |
| 2024-09-30 |
12.05 |
$15.26 |
0.79 |
| 2024-06-30 |
6.37 |
$15.49 |
0.41 |
| 2024-03-31 |
5.97 |
$16.04 |
0.37 |
| 2023-12-31 |
5.90 |
$16.53 |
0.36 |
| 2023-09-30 |
6.30 |
$16.72 |
0.38 |
| 2023-06-30 |
3.99 |
$16.94 |
0.24 |
| 2023-03-31 |
3.27 |
$16.53 |
0.20 |
| 2022-12-31 |
3.36 |
$16.09 |
0.21 |
| 2022-09-30 |
3.36 |
$15.74 |
0.21 |
| 2022-06-30 |
3.87 |
$15.55 |
0.25 |
| 2022-03-31 |
4.20 |
$15.49 |
0.27 |
| 2021-12-31 |
5.58 |
$15.35 |
0.36 |
| 2021-09-30 |
5.98 |
$15.51 |
0.39 |
| 2021-06-30 |
6.49 |
$15.29 |
0.42 |
| 2021-03-31 |
8.25 |
$15.51 |
0.53 |
| 2020-12-31 |
8.23 |
$15.70 |
0.52 |
| 2020-09-30 |
10.66 |
$15.82 |
0.67 |
| 2020-06-30 |
11.94 |
$15.81 |
0.75 |
| 2020-03-31 |
9.09 |
$15.50 |
0.59 |
| 2019-12-31 |
13.78 |
$15.34 |
0.90 |
| 2019-09-30 |
12.10 |
$15.02 |
0.81 |
| 2019-06-30 |
11.46 |
$14.97 |
0.77 |
| 2019-03-31 |
12.62 |
$15.05 |
0.84 |
| 2018-12-31 |
11.64 |
$14.95 |
0.78 |
| 2018-09-30 |
9.70 |
$14.56 |
0.67 |
| 2018-06-30 |
5.62 |
$14.37 |
0.39 |
| 2018-03-31 |
3.19 |
$14.14 |
0.23 |
| 2017-12-31 |
4.20 |
$13.76 |
0.31 |
| 2017-09-30 |
3.73 |
$13.73 |
0.27 |
| 2017-06-30 |
3.82 |
$14.04 |
0.27 |
| 2017-03-31 |
4.74 |
$14.10 |
0.34 |
| 2016-12-31 |
7.20 |
$14.88 |
0.48 |
| 2016-09-30 |
8.35 |
$15.13 |
0.55 |
| 2016-06-30 |
12.01 |
$14.61 |
0.82 |
| 2016-03-31 |
8.03 |
$14.17 |
0.57 |
| 2015-12-31 |
8.40 |
$13.42 |
0.63 |
| 2015-09-30 |
5.01 |
$13.07 |
0.38 |
| 2015-06-30 |
3.28 |
$13.27 |
0.25 |
| 2015-03-31 |
4.88 |
$13.58 |
0.36 |
| 2014-12-31 |
8.03 |
$13.96 |
0.58 |
| 2014-09-30 |
7.05 |
$13.82 |
0.51 |
| 2014-06-30 |
8.90 |
$13.25 |
0.67 |
| 2014-03-31 |
8.10 |
$12.67 |
0.64 |
| 2013-12-31 |
10.20 |
$11.87 |
0.86 |
| 2013-09-30 |
14.71 |
$11.60 |
1.27 |
| 2013-06-30 |
14.34 |
$11.64 |
1.23 |
| 2013-03-31 |
14.52 |
$11.34 |
1.28 |
| 2012-12-31 |
13.53 |
$10.98 |
1.23 |
| 2012-09-30 |
21.20 |
$9.50 |
2.23 |
| 2012-06-30 |
17.49 |
$7.71 |
2.27 |
| 2012-03-31 |
23.24 |
$6.31 |
3.68 |
| 2011-12-31 |
8.84 |
$4.81 |
1.84 |
| 2011-09-30 |
9.27 |
$3.92 |
2.36 |
| 2011-06-30 |
9.27 |
$3.27 |
2.83 |
| 2011-03-31 |
4.39 |
$2.55 |
1.72 |
| 2010-12-31 |
2.41 |
$1.93 |
1.25 |
| 2010-09-30 |
3.09 |
$1.66 |
1.87 |
| 2010-06-30 |
3.15 |
$1.39 |
2.26 |
| 2010-03-31 |
2.41 |
$1.05 |
2.29 |
| 2009-12-31 |
1.55 |
$0.95 |
1.62 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.222B |
$0.200B |
|
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|
